Immunovant Stock Technical Analysis
| IMVT Stock | USD 26.06 0.77 2.87% |
As of the 29th of January, Immunovant retains the Risk Adjusted Performance of 0.1262, downside deviation of 2.45, and Market Risk Adjusted Performance of 1.0. Immunovant technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immunovant Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immunovant, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmunovantImmunovant | Build AI portfolio with Immunovant Stock |
Immunovant Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 40.31 | Strong Buy | 14 | Odds |
Most Immunovant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunovant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunovant, talking to its executives and customers, or listening to Immunovant conference calls.
Is there potential for Biotechnology market expansion? Will Immunovant introduce new products? Factors like these will boost the valuation of Immunovant. Market participants price Immunovant higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Immunovant listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Immunovant requires distinguishing between market price and book value, where the latter reflects Immunovant's accounting equity. The concept of intrinsic value—what Immunovant's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Immunovant's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immunovant's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunovant is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immunovant's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Immunovant 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunovant's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunovant.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Immunovant on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Immunovant or generate 0.0% return on investment in Immunovant over 90 days. Immunovant is related to or competes with Crinetics Pharmaceuticals, Viking Therapeutics, Kymera Therapeutics, NewAmsterdam Pharma, Praxis Precision, Dyne Therapeutics, and ACADIA Pharmaceuticals. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoim... More
Immunovant Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunovant's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunovant upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.45 | |||
| Information Ratio | 0.1393 | |||
| Maximum Drawdown | 20.44 | |||
| Value At Risk | (3.63) | |||
| Potential Upside | 5.31 |
Immunovant Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunovant's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunovant's standard deviation. In reality, there are many statistical measures that can use Immunovant historical prices to predict the future Immunovant's volatility.| Risk Adjusted Performance | 0.1262 | |||
| Jensen Alpha | 0.512 | |||
| Total Risk Alpha | 0.2418 | |||
| Sortino Ratio | 0.1968 | |||
| Treynor Ratio | 0.9934 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunovant's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunovant January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1262 | |||
| Market Risk Adjusted Performance | 1.0 | |||
| Mean Deviation | 2.49 | |||
| Semi Deviation | 2.14 | |||
| Downside Deviation | 2.45 | |||
| Coefficient Of Variation | 621.61 | |||
| Standard Deviation | 3.47 | |||
| Variance | 12.02 | |||
| Information Ratio | 0.1393 | |||
| Jensen Alpha | 0.512 | |||
| Total Risk Alpha | 0.2418 | |||
| Sortino Ratio | 0.1968 | |||
| Treynor Ratio | 0.9934 | |||
| Maximum Drawdown | 20.44 | |||
| Value At Risk | (3.63) | |||
| Potential Upside | 5.31 | |||
| Downside Variance | 6.02 | |||
| Semi Variance | 4.6 | |||
| Expected Short fall | (2.94) | |||
| Skewness | 1.67 | |||
| Kurtosis | 5.21 |
Immunovant Backtested Returns
Currently, Immunovant is not too volatile. Immunovant holds Efficiency (Sharpe) Ratio of 0.0475, which attests that the entity had a 0.0475 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Immunovant, which you can use to evaluate the volatility of the firm. Please check out Immunovant's Downside Deviation of 2.45, market risk adjusted performance of 1.0, and Risk Adjusted Performance of 0.1262 to validate if the risk estimate we provide is consistent with the expected return of 0.12%. Immunovant has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.55, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immunovant's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immunovant is expected to be smaller as well. Immunovant right now retains a risk of 2.61%. Please check out Immunovant maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Immunovant will be following its current trending patterns.
Auto-correlation | -0.04 |
Very weak reverse predictability
Immunovant has very weak reverse predictability. Overlapping area represents the amount of predictability between Immunovant time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunovant price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Immunovant price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.31 |
Immunovant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Immunovant Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Immunovant volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Immunovant Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunovant on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunovant based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunovant price pattern first instead of the macroeconomic environment surrounding Immunovant. By analyzing Immunovant's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunovant's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunovant specific price patterns or momentum indicators. Please read more on our technical analysis page.
Immunovant January 29, 2026 Technical Indicators
Most technical analysis of Immunovant help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunovant from various momentum indicators to cycle indicators. When you analyze Immunovant charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1262 | |||
| Market Risk Adjusted Performance | 1.0 | |||
| Mean Deviation | 2.49 | |||
| Semi Deviation | 2.14 | |||
| Downside Deviation | 2.45 | |||
| Coefficient Of Variation | 621.61 | |||
| Standard Deviation | 3.47 | |||
| Variance | 12.02 | |||
| Information Ratio | 0.1393 | |||
| Jensen Alpha | 0.512 | |||
| Total Risk Alpha | 0.2418 | |||
| Sortino Ratio | 0.1968 | |||
| Treynor Ratio | 0.9934 | |||
| Maximum Drawdown | 20.44 | |||
| Value At Risk | (3.63) | |||
| Potential Upside | 5.31 | |||
| Downside Variance | 6.02 | |||
| Semi Variance | 4.6 | |||
| Expected Short fall | (2.94) | |||
| Skewness | 1.67 | |||
| Kurtosis | 5.21 |
Immunovant January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immunovant stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 20,092 | ||
| Daily Balance Of Power | (0.87) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 26.42 | ||
| Day Typical Price | 26.30 | ||
| Price Action Indicator | (0.74) |
Additional Tools for Immunovant Stock Analysis
When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.